Literature DB >> 11863083

Diabetic renal disease in African Americans.

Errol D Crook1.   

Abstract

Diabetic nephropathy (DN) is the No. 1 cause of end-stage renal disease in the United States and is highly prevalent in African Americans. Almost all DN in African Americans is caused by type 2 diabetes. Glycemic control and control of blood pressure are essential to prolong renal survival and to protect against cardiovascular events. Among African Americans, diabetic nephropathy seems to affect women more than men, which may be related to increased rates of obesity and diabetes in African American women. In addition to gender, the development of albuminuria, family history, and possibly birth weight are factors that predict progression of renal disease in African Americans with DN. The impact of glycemic control, appropriate antihypertensives, and the optimal level of blood pressure control in African Americans with advanced DN require further study. This article will review the clinical characteristics, risk factors, predictors of disease progression, and treatment of diabetic nephropathy in African Americans.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11863083     DOI: 10.1097/00000441-200202000-00004

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  12 in total

1.  Impact of Cardiovascular Risk Factors on Graft Outcome Disparities in Black Kidney Transplant Recipients.

Authors:  David J Taber; Kelly J Hunt; Cory E Fominaya; Elizabeth H Payne; Mulugeta Gebregziabher; Titte R Srinivas; Prabhakar K Baliga; Leonard E Egede
Journal:  Hypertension       Date:  2016-07-11       Impact factor: 10.190

Review 2.  Diabetic nephropathy in African-American patients.

Authors:  Errol D Crook; Sejal R Patel
Journal:  Curr Diab Rep       Date:  2004-12       Impact factor: 4.810

3.  Sex, weight status, and chronic kidney disease among African Americans: the Jackson Heart Study.

Authors:  Marino A Bruce; Bettina M Beech; Errol D Crook; Mario Sims; Derek M Griffith; Sean L Simpson; Jamy Ard; Keith C Norris
Journal:  J Investig Med       Date:  2013-04       Impact factor: 2.895

Review 4.  Are low target blood pressure goals justified in persons with diabetes mellitus?

Authors:  Errol D Crook; Latha Velusamy
Journal:  Curr Hypertens Rep       Date:  2003-06       Impact factor: 5.369

Review 5.  The role of anemia management in improving outcomes for African-Americans with chronic kidney disease.

Authors:  Janice P Lea; Keith Norris; Lawrence Agodoa
Journal:  Am J Nephrol       Date:  2008-04-24       Impact factor: 3.754

Review 6.  Social environmental stressors, psychological factors, and kidney disease.

Authors:  Marino A Bruce; Bettina M Beech; Mario Sims; Tony N Brown; Sharon B Wyatt; Herman A Taylor; David R Williams; Errol Crook
Journal:  J Investig Med       Date:  2009-04       Impact factor: 2.895

7.  Pharmacist-Led, Technology-Assisted Study to Improve Medication Safety, Cardiovascular Risk Factor Control, and Racial Disparities in Kidney Transplant Recipients.

Authors:  David J Taber; Mulugeta Gebregziabher; Aurora Posadas; Caitlin Schaffner; Leonard E Egede; Prabhakar K Baliga
Journal:  J Am Coll Clin Pharm       Date:  2018-06-21

8.  Protein-energy malnutrition during early gestation in sheep blunts fetal renal vascular and nephron development and compromises adult renal function.

Authors:  Louise J Lloyd; Thomas Foster; Phillip Rhodes; Stewart M Rhind; David S Gardner
Journal:  J Physiol       Date:  2011-11-21       Impact factor: 5.182

9.  Microalbuminuria among Type 1 and Type 2 diabetic patients of African origin in Dar Es Salaam, Tanzania.

Authors:  Janet Joy Kachuchuru Lutale; Hrafnkell Thordarson; Zulfiqarali Gulam Abbas; Kåre Vetvik
Journal:  BMC Nephrol       Date:  2007-01-15       Impact factor: 2.388

10.  Hypertension and impaired renal function accompany juvenile obesity: the effect of prenatal diet.

Authors:  P J Williams; L O Kurlak; A C Perkins; H Budge; T Stephenson; D Keisler; M E Symonds; D S Gardner
Journal:  Kidney Int       Date:  2007-04-11       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.